All lobbying filings
BGR Government Affairs
BGR Government Affairs filed a Q1 report for Akebia Therapeutics, Inc. on April 20, 2026, reporting $60,000 in lobbying income.
Lobbying for Akebia Therapeutics, Inc. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
6
-
ROBERT WOODPreviously held: Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
-
ROBB WALTONPreviously held: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
-
BRENT ALAN DEL MONTEPreviously held: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
-
DANIEL FARMERPreviously held: Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space
-
JOEL D. BAILEYPreviously held: COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall
-
CHRIS KELLYPreviously held: Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn
Government bodies contacted
2
Lobbying activity
1
Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and legislation to provide greater access to kidney care.